Corvus Pharmaceuticals, Inc. (CRVS) Misses Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. SPY
4. PANW
5. AAPL

6. USO
7. SPGI
8. ENOV
9. GTLB
10. NIO

Price: $14.27 --0%

EPS Growth %: -58.3%

Today's EPS Names:
RCBC, GASS, YSG, More

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) reported Q4 EPS of ($0.18), $0.06 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Corvus Pharmaceuticals, Inc. (CRVS) click here.

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!